Methods and compounds for eliminating immune responses to therapeutic agents Grant US-11787849-B2 United States of America 17 Oct 2023
Immunogenic peptides and their use in immune disorders Grant US-11718650-B2 United States of America 08 Aug 2023
Compositions and method for optimized peptide vaccines using residue optimization Grant US-11464842-B1 United States of America 11 Oct 2022
Methods and compositions for adoptive cell therapy Grant US-11266739-B2 United States of America 08 Mar 2022
Method for the detection, preparation and depletion of CD4+ t lymphocytes Grant US-11226332-B2 United States of America 18 Jan 2022
Immunogenic peptides for use in the prevention and/or treatment of infectious diseases… Grant US-11193114-B2 United States of America 07 Dec 2021
Immunotherapy targeting intracellular pathogens Grant US-10982196-B2 United States of America 20 Apr 2021
Animal models for evaluating pharmaceutical compounds Grant US-10729791-B2 United States of America 04 Aug 2020
Immunogenic peptides and their use in immune disorders Grant US-10662232-B2 United States of America 26 May 2020
Immunogenic control of tumours and tumour cells Grant US-10617748-B2 United States of America 14 Apr 2020
Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy Grant US-9347937-B2 United States of America 24 May 2016
Cloning and recombinant productions of Vespula venom protease and methods of use thereof Grant US-8802836-B2 United States of America 12 Aug 2014
Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy Grant US-8491910-B2 United States of America 23 Jul 2013